Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

NCT06785974 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06785974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06785974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
February 28, 2030
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, immune-related adverse event, melanoma